education
|
points
Download App
Philippines
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Points
Download App
Country
Philippines
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Advertisement
Advertisement
MIMS home
Drugs
Info
Urica
Urica
febuxostat
Manufacturer:
Cathay Drug
Distributor:
Cathay YSS
SELECT
Concise Prescribing Info
Full Prescribing Info
Contents
Description
Action
Indications/Uses
Dosage/Direction for Use
Overdosage
Contraindications
Special Precautions
Use In Pregnancy & Lactation
Adverse Reactions
Drug Interactions
Storage
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Full Prescribing Info
Contents
Description
Action
Indications/Uses
Dosage/Direction for Use
Overdosage
Contraindications
Special Precautions
Use In Pregnancy & Lactation
Adverse Reactions
Drug Interactions
Storage
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Contents
Febuxostat
Indications/Uses
Chronic hyperuricemia.
Click to view Urica detailed prescribing information
Dosage/Direction for Use
Adult
Initially 40 mg once daily. May increase to 80 mg in patients who do not achieve a serum uric acid of <6 mg/dL. Usual dose: 40-80 mg once daily.
Click to view Urica detailed prescribing information
Overdosage
View
Urica overdosage
for action to be taken in the event of an overdose.
Administration
May be taken with or without food: May be taken w/o regard to antacid use.
Contraindications
Hypersensitivity. Azathioprine, mercaptopurine or theophylline.
Click to view Urica detailed prescribing information
Special Precautions
Increased gout flares. Monitor signs & symptoms of MI & stroke. Elevations in liver enzymes. Not recommended in patients w/ increased rate of urate formation. Severe renal & hepatic impairment. Pregnancy & lactation. Childn.
Click to view Urica detailed prescribing information
Use In Pregnancy & Lactation
Click to view Urica detailed prescribing information
Adverse Reactions
Dizziness, liver function abnormalities, nausea, arthralgia & rash.
Click to view Urica detailed prescribing information
Drug Interactions
May increase plasma conc of mercaptopurine & azathioprine. May alter metabolism of theophylline.
Click to view Urica detailed prescribing information
Storage
View
Urica storage
conditions for details to ensure optimal shelf-life.
Description
View
Urica description
for details of the chemical structure and excipients (inactive components).
Action
View
Urica mechanism of action
for pharmacodynamics and pharmacokinetics details.
MIMS Class
Hyperuricemia & Gout Preparations
ATC Classification
M04AA03 - febuxostat ; Belongs to the class of preparations inhibiting uric acid production. Used in the treatment of gout.
Regulatory Classification
Rx
Presentation/Packing
Form
Urica FC tab 40 mg
Packing/Price
30's (P529.2/box)
Form
Urica FC tab 80 mg
Packing/Price
30's (P746.4/box)
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Sign up for Free to Continue Reading
Continue with Google
Sign up with email
Already a member?
Sign in
Sign up for Free to Continue Reading
Continue with Google
Sign up with email
Already a member?
Sign in